When the global SARS-CoV-2 pandemic hit, most life scientists turned to high-throughput RNA extraction, detection, and sequencing to help stop its spread. Read More

As an industry first, Avida Biomed has fully automated its novel Point-n-Seq® targeted sequencing sample prep as well as targeted methylation enrichment to a <1 day protocol, including only 10-15 minutes of hands-on time, – all achieved on Opentrons’ low cost open-platform liquid handler, the OT-2. Read More

Read how Correlia Biosystems is accelerating the efficiency and accuracy of immunoassays, and then watch the webinar with Correlia CSO, Samuel Tia, to see how they are using lab automation in their groundbreaking approach. The rapid growth of protein-based biomedical research has resulted in a need to measure protein data… Read More

In this webinar, Dr. Michael Mina shares his team’s efforts to overcome challenges in scaling infectious disease surveillance using serological testing and flexible automation. In our increasingly connected world, infectious disease outbreaks have become all too common and costly. Quick identification of the next outbreak will require a new public… Read More

Boston University DAMPLab’s Lead Lab Specialist Rita Chen created a prototype COVID-19 diagnostics workflow using Opentrons in three months. Here’s how. At the start of the COVID-19 pandemic, Boston University’s Design, Automation, Manufacturing, and Prototyping (DAMP) Lab was tasked with creating a diagnostics workflow in three months. DAMPLab’s… Read More